Cite
Langereis MA, Albulescu IC, Stammen-Vogelzangs J, et al. An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats. NPJ Vaccines. 2021;6(1):122doi: 10.1038/s41541-021-00390-9.
Langereis, M. A., Albulescu, I. C., Stammen-Vogelzangs, J., Lambregts, M., Stachura, K., Miller, S., Bosco-Lauth, A. M., Hartwig, A. E., Porter, S. M., Allen, M., Mogler, M., van Kuppeveld, F. J. M., Bosch, B. J., Vermeij, P., de Groof, A., Bowen, R. A., Davis, R., Xu, Z., & Tarpey, I. (2021). An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats. NPJ vaccines, 6(1), 122. https://doi.org/10.1038/s41541-021-00390-9
Langereis, Martijn A, et al. "An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats." NPJ vaccines vol. 6,1 (2021): 122. doi: https://doi.org/10.1038/s41541-021-00390-9
Langereis MA, Albulescu IC, Stammen-Vogelzangs J, Lambregts M, Stachura K, Miller S, Bosco-Lauth AM, Hartwig AE, Porter SM, Allen M, Mogler M, van Kuppeveld FJM, Bosch BJ, Vermeij P, de Groof A, Bowen RA, Davis R, Xu Z, Tarpey I. An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats. NPJ Vaccines. 2021 Oct 20;6(1):122. doi: 10.1038/s41541-021-00390-9. PMID: 34671047; PMCID: PMC8528862.
Copy
Download .nbib
